Incorrect information

A Tale of Three Pharmaceuticals: Abbott Labs, Pfizer and Eli Lilly & Co.

That is correct. Actos patent expiration has no impact on LLY since it is now a 100% Takeda drug. What should be mentioned is the expiration of patents for Cymbalta, Evista, and Gemzar within the next few years. Along with Zyprexa that indicates that the drugs responsible for the majority of sales with be off patent in the next few years.